世界最新医学信息文摘（电子版）
世界最新醫學信息文摘（電子版）
세계최신의학신식문적（전자판）
World Latest Medicine Information
2013年
9期
65-65
,共1页
膀胱癌%吡柔比星%卡介苗%膀胱内灌注
膀胱癌%吡柔比星%卡介苗%膀胱內灌註
방광암%필유비성%잡개묘%방광내관주
bladder%pyrazole soft stars%than BCG bladder%perfusion
目的：探讨吡柔比星和卡介苗两种不同药物膀胱癌注射化疗，预防浅表性膀胱癌术后复发的疗效和安全性。方法对60例行尿道膀胱癌电切术后的浅表性膀胱癌患者，随机分为两组，每组30例，一组用吡柔比星，一组用卡介苗。分别于术后1-2周开始膀胱灌注，比较两组肿瘤复发率和并发症。结果随访6-36个月，两组的复发率分别为10%和13.3%，卡介苗并发症多于吡柔比星。结论吡柔比星膀胱灌注预防浅表性膀胱癌术后复发疗效满意，副作用轻，耐受性良好。
目的：探討吡柔比星和卡介苗兩種不同藥物膀胱癌註射化療，預防淺錶性膀胱癌術後複髮的療效和安全性。方法對60例行尿道膀胱癌電切術後的淺錶性膀胱癌患者，隨機分為兩組，每組30例，一組用吡柔比星，一組用卡介苗。分彆于術後1-2週開始膀胱灌註，比較兩組腫瘤複髮率和併髮癥。結果隨訪6-36箇月，兩組的複髮率分彆為10%和13.3%，卡介苗併髮癥多于吡柔比星。結論吡柔比星膀胱灌註預防淺錶性膀胱癌術後複髮療效滿意，副作用輕，耐受性良好。
목적：탐토필유비성화잡개묘량충불동약물방광암주사화료，예방천표성방광암술후복발적료효화안전성。방법대60례행뇨도방광암전절술후적천표성방광암환자，수궤분위량조，매조30례，일조용필유비성，일조용잡개묘。분별우술후1-2주개시방광관주，비교량조종류복발솔화병발증。결과수방6-36개월，량조적복발솔분별위10%화13.3%，잡개묘병발증다우필유비성。결론필유비성방광관주예방천표성방광암술후복발료효만의，부작용경，내수성량호。
Objective to investigate two different drugs actos is soft than the star and the BCG vaccine injection bladder cancer chemotherapy, efficacy and safety of prevention of postoperative recurrence of superficial bladder cancer. Methods 60 routine urethral cutting postoperative patients with superifcial bladder cancer, bladder cancer were randomly divided into two groups, 30 cases in each group, a group with actos is soft than star, a set of BCG vaccine. In 1-2 weeks after operation respectively to bladder perfusion, compared two groups of tumor recurrence rate and complication. Results followed up for 6 to 36 months, two groups of recurrence rates were 10%and 13.3%respectively, the BCG vaccine complications than actos is soft than the star. Conclusion pyrazole soft than star bladder perfusion prevention of postoperative recurrence of superifcial bladder cancer curative effect satisfaction, side effect is light, well tolerated.
